Abstract
In a paper recently published in Science (Greenwood et al., 2019), Greenwood and colleagues now describe a fascinating example of how partitioning of a small lipophilic molecule into a phase-separated cellular constituent, the lipid droplet (LD), contributes to its antibacterial action against Mycobacterium tuberculosis.